ID 993 -
Lactobacillus plantarum BFE 1685
PL: Lactobacillus plantarum BFE 1685
EN: Lactobacillus plantarum BFE 1685
Pdf: Lactobacillus plantarum BFE 1685
Oświadczenie (2)
- probiotycznych
- naturalne mechanizmy obronne / układ odpornościowy
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claim is Lactobacillus plantarum BFE 1685.
The identity and characteristics of the strain Lactobacillus plantarum BFE 1685 have been determined using phenotypic and genotypic methods (Vizoso Pinto et al., 2006).
No indication of the deposition of the strain in an internationally recognised culture collection was found in the information provided or in the literature.
The Panel considers that the food constituent, Lactobacillus plantarum BFE 1685, which is the subject of the health claim, is sufficiently characterised.
2.1. Naturalna obrona organizmu, system immunologiczny (ID 993)
The claimed effect is “natural defences/immune system”. The Panel assumes that the target population is the general population.
The claimed effect is not sufficiently defined and no further details were given in the proposed wording or the clarifications provided by Member States. Given the multiple roles of the immune system, the specific aspect of immune function that is the subject of the claim needs to be specified, but it has not been indicated in the information provided. The Panel notes that several effects/parameters were mentioned in the information provided (e.g. related to adhesion properties of the bacterial strains, to technological features and functional characteristics of “probiotic” strains, to effects on monocyte-derived dendritic cells from patients allergic to house dust mite, to the cytokine-inducing pattern of lactic bacteria, to anti-inflammatory properties using the murine induced colitis model, to bacterial translocation using the mouse colitis model, and to identification and characterisation aspects of bacterial strains) and that it was not possible to establish which specific effect is the target for the claim.
The Panel considers that the claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.
Warunki i możliwe ograniczenia stosowania oświadczenia
At least 108 CFU/day